A Phase 1, Open-Label, Dose-Escalation and -Expansion Study of the Bruton Tyrosine Kinase-Targeted Protein-Degrader BGB-16673 in Patients With B-Cell Malignancies

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Locations

Greeley Campus
Harmony Campus
Medical Center of the Rockies
Poudre Valley Hospital

Principal Investigator
Photograph of Steven Schuster

Steven Schuster

Study ID

Protocol Number: 23-0503

More information available at ClinicalTrials.gov: NCT05006716

Categories

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers